A Study to Evaluate sPD-L1 Clearance in Patients Undergoing Plasma Exchange Therapy


About this study

The purpose of this study is to establish the clearance rate of sPD-L1 in patients undergoing plasma exchange, and to establish the kinetics of sPD-L1 regeneration in vivo.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Patients ≥ 18 years old.
  • Patients undergoing plasma exchange therapy for a medical indication.

Exclusion Criteria: 

  • Age < 18 years old.


Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Jeffrey Winters, M.D.

Open for enrollment

Contact information:

Heather Dale R.N.



More information


Publications are currently not available

Mayo Clinic Footer